A 2-Day Training Course Delivered By
Lieven Annemans

Prof. Dr. Lieven Annemans

  • Prof. Dr. Lieven Annemans has participated in more than 400 health economic evaluations in over 20 countries across a wide spectrum of therapeutic areas. He has also been involved as expert in a large number of Health Technology Assessments (HTAs) and is actively involved in HTA on a European level.
  • A unique profile: academic professor, past-president ISPOR, consultant and former pharma executive.
  • Highly respected for his vast international and cross-therapeutic experience, Lieven is a much sought-after advisor and educator to health policy makers and the innovative healthcare industry.
  • Author of Health economics for non-economists (Pelckmans Pro, 2018).


  1. The full meaning of QALYs and ICERs, and how to calculate them.
  2. Commonly used health economic modelling techniques.
  3. Key principles of cost analysis and budget impact analysis.
  4. The 10 guidelines for conducting and reporting health economic evaluations.
  5. How to assess peer reviewed health economic articles.
  6. How health economic evaluations are integrated in clinical trial programmes.
  7. The use of health economic evaluations in pricing & reimbursement decision making.
  8. The importance of health economic evaluations along the innovation life cycle.

Additional Benefits

  • Face-to-face training by Prof. Dr. Lieven Annemans combines very productive learning with great fun!
  • Exchange experiences and discuss issues with your peers from other companies, functions, therapy areas and countries.


Why You Should Attend

The Content: This health economics course not only provides you with an explanation of concepts and methods, it also discusses the integration of health economic evaluations in clinical development and brand marketing plans (with practical examples), as well as the perspective of the decision maker - including examples of successful applications of health economic evaluations.

The Expert: Prof. Dr. Lieven Annemans not only has a wide international experience in health economic evaluations (over 200 completed projects with over 30 different pharmaceutical or medical device companies) but also built a very strong reputation within the international pharmaco-economic community as a high-impact trainer. Throughout his career, Lieven has worked in pharmaceutical companies, in health care policy environments, in consultancy and in academic positions.

The Health Economics for Non-Health-Economists course is the only available public training course delivered by Prof. Lieven Annemans on the topic of health economics.

What is the difference with the Basics of Health Economics online self-study programme ?

  • The 2-day course has more breadth and depth in both theory (lectures) and practice (group work). For instance, the 2-hour module on the “Guidelines for Health Economic Evaluations” is highly valued because of the interactive group work session on a health economic publication.
  • In a classroom training, whether face-to-face or virtual, you learn a lot from your industry peers because of the exchange of experiences and ideas and the discussions about issues you face in your function. The (physical) face-to-face version of the 2-day course is obviously most impactful in that respect because the Q&A sessions are very rich and because of the many opportunities for conversations with your peers outside the formal programme.
  • Participating in the (physical) face-to-face course gives the opportunity to meet Prof. Dr. Lieven Annemans and discuss your own projects/issues with him during the coffee and lunch breaks.

Agenda of the Health Economics for Non-Health-Economists course

The below agenda is for the face-to-face format. The online version of this course will cover the same modules, but the format and timing will be adapted to suit the online training setting. 

Timing of the online course on both days will be: 

  • AM: 10-12 CET
  • PM: 13-17 CET

Day 1



Welcome & General Introduction


Health Economic Evaluations: Why and How


  • Why health economic evaluations receive increasing attention
  • Key definitions & terminology: talking the same language
  • Key principles of health economic evaluations
    • QALY: The maths – examples
    • Balancing costs vs. health effect
    • The Incremental Cost-Effectiveness Ratio (ICER) and its thresholds

Coffee Break


Health Economic Modelling – Commonly Used Models

  • Simple decision trees (+ real examples)
  • Markov models (+ real examples)


Cost Analysis and Budget Impact Analysis. Key Principles

  • The perspective of the study (e.g. building in absenteeism in the value message?)
  • How to deal with current benefits versus benefits in the far future?
  • Budget impact implications: state-of-the-art
  • Exercise on budget impact
15:15Coffee Break


Prospective Research for Health Economic Evaluations

  • Aligning the collection of health economic data and clinical data
  • Conflicts between the clinical and the health economic perspective
  • Practical steps for prospective health economic studies
  • Issues with integrating clinical data in health economic evaluations
  • Break-Out Session: “To HE or not to HE?”




Group Dinner


Day 2



Guidelines for Health Economic Evaluations


  • What distinguishes a good from a bad health economic evaluation?
  • What can one do to increase the credibility of health economic messages in the value message?
  • A 10-item checklist for a good health economic paper
  • Break-Out Session: how to distinguish a good health economic paper from a poor quality paper
10:30Coffee Break


Use of Health Economic Evaluations in Price & Reimbursement Decision Making

  • The large differences in payer expectations
  • Communication challenge: from very simple messages to high tech requirements
  • Pitfalls of health economic evaluations: why some messages fail
  • The secrets behind the QALY


Health Economic Evaluation in a Pharmaceutical Drug’s Life Cycle

  • Role of early economic models
  • Organisation and process within HQ and affiliates
  • Post-launch and the use of real world data
14:15Coffee Break


Break-Out Session: Developing Together a Health Economic Strategy


Final Discussion



>> Click here if you wish to receive the PDF brochure of this course

Learning Methodology

Prof. Lieven Annemans is very experienced in leading interactive sessions and will actively engage participants in discussions. In addition, two exercises will be used to help bring theory into practice.

One of the most valuable aspects of attending any CELforPharma course is not only being able to have your specific questions answered by a leading expert, but also having the opportunity to share experiences and have in-depth discussions with your international peers.

infoThe typical audience size of our courses ranges from 6 to 24 (max) participants.

Who Should Attend?

As the course title suggests, this course is designed for non-health-economists.

As pharma companies are facing ever-increasing hurdles to optimise market access for their brands, all managers in product development and marketing should attend this course so that they can contribute to a successful integration of health economic evaluations into clinical and brand plans.

While most of the examples and exercises discussed in this course are about pharmaceuticals, this course is equally relevant to, and has always been highly valued by (see testimonials), executives from the medical devices industry.


Past Participants

Below is a non-exhaustive list of past participants who have benefited from attending this course.


Job Title



Medical Director BeneluxALKNetherlands
Director, Global Public Policy & AffairsAstraZenecaUnited Kingdom
Sr Medical Director, Regional Medical Affairs Head Immunology, EMEABaxaltaSwitzerland
Head of Health Economics Hospital Care DACHBaxterGermany
Market Access Manager, Asia PacificBayer Healthcare PharmaceuticalsSingapore
Market Access ManagerBiogenIreland
Head Market Access & External AffairsBoehringer IngelheimNetherlands
Product Manager Immuno-Oncology SwitzerlandBristol-Myers SquibbSwitzerland
Manager, Government RelationsCelgeneBelgium
Health Outcomes & Pharmacoeconomics ManagerChiesiNetherlands
Medical AdvisorCSL BehringBelgium
Medical Director, Clinical R&D GastroFerringDenmark
Generics Portfolio & Marketing - Mature & Emerging MarketsFresenius KabiGermany
Market Access Manager NL accountsGenzymeNetherlands
Product ManagerGileadBelgium
Director Strategic Pricing & AllocationsGlaxoSmithKlineBelgium
Senior Director Commercial AssessmentGruenenthalGermany
Group Therapeutic Area DirectorJanssenHungary
Sr. Principal Product Stewardship, Compliance & EU PackagingJohnson & JohnsonBelgium
RA & Compliance ManagerLEO PharmaSwitzerland
PRA ManagerLillyNetherlands
EUCAN Customer Engagement / Experience LeadMerck Sharp & DohmeSwitzerland
Market Access Head Franchise ManagementNovartisGermany
Sr Global Product ManagerNovo NordiskSwitzerland
International Health Policy LeaderRocheSwitzerland
Medical Manager CardiovascularSanofiBelgium
Head of Market Access & Corporate AffairesTakedaSwitzerland
Director, Specialty Life Cycle Initiatives Global Specialty MedicinesTevaBelgium
Director, New Product PlanningUCBBelgium



Dates & Locations

All CELforPharma courses are held live online (hosted in Zoom) or in top-class four or five star hotels situated in easily accessible locations, either close to an international airport or near public transportation links in city centre locations.
  • 10-11 December 2020, live online

  • 16-17 March 2021, live online

  • 8-9 June 2021, live online

  • 30 September - 1 October 2021, Brussels or live online

  • 9-10 December 2021, Brussels or live online


All the above courses (except for the online courses) take place at the Courtyard Marriott Brussels Hotel which is located 15 minutes from Brussels National Airport by complimentary hotel shuttle or taxi and 30 minutes by taxi from Brussels South train station (Thalys, TGV, Eurostar). 


Address: Avenue des Olympiades 6, 1140 Brussels, Belgium
Tel: +32 2 337 08 08

Hotel Booking Assistance

Having built a strong relationship with each hotel, CELforPharma has secured preferential room rates for our delegates who book their accommodation three weeks or more prior to the course. Upon your registration, we will help you make your hotel booking. For any assistance in this matter please do not hesitate to contact Sarah Nissen, Senior Programme Coordinator (sarah.nissen@celforpharma.com, tel +32 (0)2 709 01 46).

Included in the Registration Fee for the live online course​

  • Access to an expert led course in real-time, using an interactive platform for break-out rooms, whiteboard exercises, polling, plenary discussions and chats
  • Course material, which will be provided to you in both digital format (by email) and in hard copy (by post, so you can make notes during the course)
  • Certificate of attendance signed by the expert and CELforPharma
  • Flexible transfer option


Included in the Registration Fee​ for the face-to-face course

  • Course Material (Digital & Print Versions)
  • Coffee, Tea & Refreshments During the Course
  • Lunch During the Course
  • A Group Dinner on the First Day
  • Certificate of Attendance Signed by the Expert
  • Flexible Transfer Option
  • Optimal Safety: Small Groups and Spacious Seating


Group Discounts

Team discounts can be offered to 3 or more delegates from the same company.
Contact Inge Cornelis, Director Commercial Communications, (inge.cornelis@celforpharma.com) for more details.


How to Register

  1. Click the "Register Here" button on this page.
  2. Choose a course date, then fill out your personal details and company / invoicing details.
  3. Choose to pay via bank transfer or by credit card.
  4. Click "Confirm Registration". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.

For assistance in registering, raising a PO or invoicing, please do not hesitate to contact Kealeigh Steel.
(email: kealeigh.steel@celforpharma.com or call: +32 2 709 01 45)


Transfer & Cancellation Policy

Flexible Transfer

  • If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
  • Alternatively, the registrant can transfer once at no extra cost, until 3 weeks prior to the event, to another course held before 31 December 2021.

Participant Cancellation

  • Up to 6 weeks prior to the course: cancellation fee of € 400 per participant.
  • Up to 5 weeks prior to the course: 25% of the invoiced registration fee.
  • Up to 4 weeks prior to the course: 50% of the invoiced registration fee.
  • Up to 3 weeks prior to the course: 75% of the invoiced registration fee.
  • Fewer than 3 weeks or if no notification received: registrant liable to pay invoiced registration fee.
  • If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.

Related Courses